Skip to content

Virologic response to HIV treatment differs by race among US patients

Majority of patients lost to follow-up still alive one year later, Ugandan study shows

Inflammation signals heart disease risk in people with HIV

Raltegravir approved for first-line use in European Union

HIV treatment may induce protective immunity in brain, monkey study finds

Early treatment and interruption makes no difference to disease progression, study finds

Clinical officers and nurses make similar decisions to physicians on starting antiretroviral therapy in rural Uganda

IRIS common in patients with cryptococcal meningitis who start HIV treatment, but benefits of therapy outweigh risks

Flares of genital ulcer disease common in women starting HIV treatment, could temporarily increase infectiousness